GLOBAL

CARDIAC PROSTHETIC DEVICES MARKET GROWTH ANALYSIS, 2009-2015

CURRENT TRENDS, ESTIMATES AND FORECASTS, MARKET GROWTH ANALYSIS 2009-2015
PUBLICATION:FEBRUARY,2011|REPORTCODE:ARMMR121 REPORTPRICE:$3270|NO.OFPAGES:410 TABLES/CHARTS:115

GEOGRAPHICCOVERAGE
NORTHAMERICA EUROPE ASIAPACIFIC LATINAMERICA& RESTOFWORLD

PRIMARILYFOCUSESON:
LATESTMARKETTRENDS REGIONWISEDEMANDFACTOR KEYGROWTHAREAS
www.axisresearchmind.com | Copyright 2011 | All Rights Reserved

MARKETSIZES KEYCOMPETITORSEDGE INVESTMENTSTRATEGIES

GLOBAL CARDIAC PROSTHETIC DEVICES MARKET GROWTH ANALYSIS, 2009-2015

PUBLISHED: FEBRUARY, 2011 REPORT PRICE: $3270

REPORT CODE: ARMMR121

SEGMENTATION

CARDIAC PROSTHETICDEVICES

MECHANICAL HEARTVALVES

TISSUEHEART VALVES

TRANSCATHETER HEARTVALVES

KEY COMPANIES PROFILED

MEDTRONIC, INC. AGA MEDICAL CORPORATION CARDIACASSIST, INC. COOK GROUP INCORPORATED ABBOTT VASCULAR DEVICES ATRICURE, INC CARDICA, INC. CORDIS CORPORATION ABIOMED, INC. ATRIUM MEDICAL CORP. IDEV TECHNOLOGIES CRYOLIFE INC. ADVANSOURCE BIOMATERIALS ATS MEDICAL, INC. CARDIOMEMS, INC. & many more BIOPHAN TECHNOLOGIES, INC. BIOSENSE WEBSTER, INC. BOSTON SCIENTIFIC CORP CARDIAC SCIENCE CORP.

For more information on this report, please reach us at: sales@axisresearchmind.com

Copyright 2011 | Axis Research Mind | All Rights Reserved

GLOBAL CARDIAC PROSTHETIC DEVICES MARKET GROWTH ANALYSIS, 2009-2015

PUBLISHED: FEBRUARY, 2011 REPORT PRICE: $3270

REPORT CODE: ARMMR121

REPORT FOCUS
The report Global Cardiac Prosthetic Devices - Market Growth Analysis, 2009-2015 reviews the latest trends in cardiac prosthetic devices with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for healthcare sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs), government organizations and many more in preferred locations. Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the cardiac devices industry. Anticipating a protracted recovery towards 2011, we have used CAGR to forecast 2011-2015 figures. More than 608 leading market players are identified and 82 key companies in cardiac medical devices industry that project improved market activities in the near future are profiled. The report consists of 115 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Global market watch

The broad health care division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. The evolution of cardiac devices has opened new vistas in the health care industry. Growth rate exhibited by the cardiac devices industry, even during the recession years, confirms the positive growth prospects going ahead. Global cardiac prosthetic devices market forecasts to reach at US$2.9 billion by 2015 at a CAGR of 9.5% during the analysis period 2009-2015. The North American segment accounts for approximately 40% of the global value while Europe claims approximately 30% of the market. Asia-Pacific is the fastest growing region with a CAGR of 10.5% driving a market value of US$0.5 billion by 2015. Among the product types, mechanical heart valves account more nearly half of the market value while tissue and transcatheter segments add up to the remaining half. On a global scale, CAGR projections for tissue heart valves market indicate a double digit value, indicative of an improved investment returns in the upcoming years.
Copyright 2011 | Axis Research Mind | All Rights Reserved

GETTING THE MOST FROM OUR RESEARCH ANALYSIS

For more information on this report, please reach us at: sales@axisresearchmind.com

GLOBAL CARDIAC PROSTHETIC DEVICES MARKET GROWTH ANALYSIS, 2009-2015

PUBLISHED: FEBRUARY, 2011 REPORT PRICE: $3270

REPORT CODE: ARMMR121

Geographic coverage
Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years. The Global Coverage of Cardiac Prosthetic Devices Market is North America, Europe, Asia-Pacific, Latin America and Rest of World with 19 countries, analyzed individually as follows: NORTH AMERICA USA AND CANADA EUROPE UNITED KINGDOM, GERMANY, FRANCE, ITALY, SPAIN, RUSSIA, BELGIUM AND REST OF EUROPE ASIA-PACIFIC JAPAN, CHINA, INDIA, NEW ZEALAND, SOUTH KOREA, AUSTRALIA AND REST OF ASIA-PACIFIC LATIN AMERICA BRAZIL, ARGENTINA & REST OF LATIN AMERICA REST OF THE WORLD SOUTH AFRICA, MIDDLE EAST & REST OF REST OF WORLD

Key Activities in the Cardiac devices MARKET

CARDIOTECH RECEIVES FDA APPROVAL FOR EXPORT OF SECOND GRAFT SIZE FOR CARDIOPASS EXTRA-AORTIC POST MARKET CLINICAL FOLLOW-UP (PMCF) ON PATIENTS FDA APPROVAL CLEARS THE WAY FOR BOSTON SCIENTIFICS PROMUS EVEROLIMUS ELUTING.. ATS MEDICALS OPEN PIVOT AP360, MECHANICAL HEART DEVICE, SANCTIONED BY THE CANADIAN. TANDEM HEART SYSTEM: PROMOSING DEVICE OF CARDIACASSIST, INC EXCEEDS 1300 PROCEDURES
Copyright 2011 | Axis Research Mind | All Rights Reserved

ATRIUM MEDICALS FIRST IN-MAN (FAM), DRUG ELUTING CLINICAL TRIAL USING CINATRA. SIEMENS ACUSON SC2000: THE REVOLUTION IN ECOCARDIOGRAPHY SIEMENS' NEW ULTRASOUND TRANSFORMS THE PROTOTYPE OF ECHOCARDIOGRAPHY ABIOMED RECEIVES 510(K) CLEARANCE FROM FDA FOR IMPELLA 2.5 DEVICE IMPELLA 2.5 ABIOMEDS PROMISING DEVICE FOR HEART TREATMENT ABBOTT SUBMITS APPLICATION FOR APPROVAL OF XIENCE V EVEROLIMUS ELUTING CORONARY.

& many more..

www.axisresearchmind.com www.axisresearchmind.com

For more information on this report, please reach us at: sales@axisresearchmind.com